Background. There is a lack of data on the burden of malaria in the first trimester of pregnancy in Africa, mainly because pregnant women generally attend the maternity clinic late. Bed nets are rarely provided to women before the second trimester of pregnancy and intermittent preventive treatment with sulfadoxine-pyrimethamine is not recommended before the second trimester, leaving women insufficiently or not protected in early pregnancy.
Despite substantial progress, malaria remains one of the major plagues for populations, particularly pregnant women, living in tropical and subtropical areas. In endemic areas, malaria threatens 125 million pregnancies each year, with sub-Saharan Africa accounting for 25% of this total burden [1] . Malaria in pregnancy caused by Plasmodium falciparum is associated with maternal and fetal anemia, stillbirth, preterm birth, and fetal growth restriction [2] [3] [4] [5] [6] [7] , these latter two contributing to low birth weight (LBW). LBW newborns have an increased risk of neonatal and infant mortality [8] , with an estimated 11% of neonatal deaths attributable to LBW due to malaria in sub-Saharan Africa. In addition, malaria in pregnancy has been associated with an increased risk of infections during childhood [9, 10] and may have long-term consequences in adulthood [11] .
In sub-Saharan Africa, preventive strategies against malaria in pregnancy recommended by the World Health Organization (WHO) are based on insecticide-treated nets (ITNs) and intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine [12] . These strategies are usually provided from the second trimester of pregnancy onwards because of the contraindication of sulfadoxine-pyrimethamine during the first trimester and the distribution of ITNs to pregnant women at their first antenatal care (ANC) visit at approximately 4-5 months of pregnancy [13] . Therefore, pregnant women may be insufficiently or not protected during the first trimester of pregnancy.
While the overall consequences of malaria in pregnancy on maternal and birth outcomes have been documented, the effect of malaria in early pregnancy-before IPTp administrationremains poorly explored [14] [15] [16] [17] [18] . Previous studies have shown that Plasmodium falciparum malaria infection was higher in early than in late pregnancy [19, 20] . However, most of the available studies were not specifically designed to assess malaria in early pregnancy and therefore women were generally recruited late in the first trimester (for a few) or early in the second trimester, which may have led to misclassification errors and underestimation of exposure. Nevertheless, all these studies showed that early malaria infections were associated with maternal anemia, fetal growth restriction, and LBW [20] . In other studies, malaria in the first trimester of pregnancy has been reported as an important risk factor for miscarriage in Southeast Asia [21] .
The REtard de Croissance Intra-uterin et PALudisme (RECIPAL) project aimed to specifically assess the burden of malaria in the first trimester of pregnancy. For that purpose, a cohort of women followed from the preconception period to delivery was established. Data collected in 387 pregnant women were used to determine the prevalence of malaria during the first trimester of pregnancy and its associated risk factors.
METHODS

Ethics Statement
This study was approved by the Ethics Committee of the Institut des Sciences Biomédicales Appliquées in Benin. All medications given for malaria before conception or any acute diseases during pregnancy were paid by the project.
Study Site and Population
The RECIPAL study started in June 2014 and the women's follow-up was completed in August 2017. It was conducted in the districts of Sô-Ava and Abomey-Calavi located 25 km north of Cotonou, Benin. Abomey-Calavi is a semiurban area, while Sô-Ava is a rural lakeside area. In both settings, malaria is hyperendemic with a mean entomological inoculation rate of 2.05 (± 1.3) infected anopheles bites/person/100 nights [22] . P. falciparum is the most common species of malaria parasite.
Our study population consisted of 387 out of a total of 411 pregnant women included and followed up in the RECIPAL study. All women were recruited before conception until getting pregnant, then for the whole duration of the pregnancy (Supplementary Figure S1 ). To be recruited, women had to meet the following criteria: negative urinary pregnancy test at inclusion, 18 to 45 years old, no current contraception, no previous fecundity issues, willingness to become pregnant, no planned travel for more than 2 months within the next 18 months, acceptance of RECIPAL protocol, and signed written informed consent.
Study Procedures
Preconceptional Follow-up
At inclusion, demographic, socioeconomic, and household characteristics were collected. On this occasion, microscopic malaria and urinary schistosomiasis screening, as well as hemoglobin (Hb) level determination, were performed. Subsequently, women were visited at home monthly. At these visits, the first day of last menstrual period (LMP) was recorded and a urinary pregnancy test (One-Step; International Holding, Germany) was performed. Anthropometric measurements, including height, weight, and mid-upper-arm circumference, were collected every 3 months. The collection of anthropometric measurements was performed according to standardized operating procedures [23] . ITN possession and use the night before the visit was collected at inclusion in the cohort.
Gestational Follow-up
Once the pregnancy was established, clinical, obstetrical, and anthropometric data (as before conception) were collected at each monthly ANC visit until delivery. Women received a new ITN at their first ANC visit; at each following visit, ITN use the night before the visit was recorded. The first ultrasound scan for dating the pregnancy was performed between 9 and 13 weeks of gestation (wg). Ultrasound scans were performed with a portable ultrasound system (high-resolution ultrasound system, 5-2 MHz C60 abdominal probe; Sonosite M-TURBO, Washington State, USA) by 4 skilled medical gynecologists. A quality control was performed on 10% of the scans. The gestational age (GA) was estimated in days based on crown-rump length measurement using the Robinson's chart [24] . Following INTERGROWTH-21st methodology, GA estimation was based either on LMP if the difference between the 2 measurements (LMP/ultrasound) was less than 7 days or on ultrasound scan if the difference was >7 days [25] . Women were screened for malaria at each scheduled ANC visit using a thick blood smear (TBS). Hb level was determined at the second ANC visit at a mean of 12 wg. In addition, women were encouraged to attend the maternity clinic anytime outside the scheduled visits in case of symptoms. In cases of fever or symptoms suggestive of malaria, a TBS and a rapid diagnostic test (RDT) (P. falciparum + pan rapid test SD Bioline Ag, IDA Foundation, the Netherlands; Biosynex, France) were performed. Because of both active and passive surveillance for malaria during pregnancy, very few patent infections would have been undetected.
Before conception, women infected with malaria and urinary schistosomiasis were treated with artemether-lumefantrine (96/480 mg twice per day for 3 days) and praziquantel (single dose of 40 mg/kg), respectively. In cases of uncomplicated malaria during the first trimester, women were treated with oral quinine (10 mg/kg/8 hours for 7 days). In cases of severe malaria, intravenous artesunate was used until oral medication could be tolerated. Anemic pregnant women (Hb concentration < 110 g/L) were treated according to the severity of anemia: 200 mg oral ferrous sulfate and 10 mg of folic acid twice a day for moderate anemia (Hb level between 70 and 110 g/L); referral to the district tertiary hospital in case of severe anemia (Hb level < 70 g/L). According to the Beninese national guidelines, a kit including the first dose of sulfadoxine-pyrimethamine for IPTp and an ITN was given to each pregnant woman at the first ANC visit. As recommended, IPTp administration was systematically postponed to the second trimester when visits were earlier.
Laboratory Procedures
The Lambaréné technique was used to quantify parasitemia, with a detection threshold estimated to be 5 parasites/µL [26, 27] . Hb level was measured with a HemoCue. Urinary schistosomiasis status was determined by the detection of Schistosoma haematobium eggs using a urine filtration technique (Nytrel filter).
Statistical Analysis
Malaria infection was defined as either a positive TBS or a positive RDT. Symptomatic malaria was defined as a positive TBS or RDT associated with history of fever in the previous 24 hours or a measured axillary temperature ≥37.5°C. Because of the short half-life of quinine, we assumed that women had a "new infection" when it occurred more than 15 days after the previous one. The first trimester was defined as a GA ≤ 14 completed wg. GA was then classified according to the month of pregnancy (first month < 6 wg, second month 7−10 wg, and third month 11−14 wg).
We aimed to determine which of the following factors were associated with microscopic malaria infection during the first trimester of pregnancy: (1) sociodemographic characteristics: age, ethnicity, marital status, education level, and residence area; (2) clinical characteristics: gravidity, body mass index (BMI), short stature (height <155 cm), anemia, and urinary schistosomiasis before conception; (3) GA and season at malaria screening during pregnancy, which were considered as time-dependent variables; (4) socioeconomic status; (5) household characteristics (number of inhabitants, possession of electricity, water sources, sanitation, and basic hygiene practices of household); and (6) malaria before conception. Prepregnancy BMI was classified a low (< 18.5 kg/m 2 ), normal (18.5-24.9 kg/m 2 ), and high (>25 kg/m 2 ), according to WHO classification. Socioeconomic status was approximated using a synthetic score combining occupation and ownership of assets, which was then categorized according to the tertiles.
We used a logistic mixed model with a random intercept at the individual level assuming that successive malaria screenings during the first trimester in the same woman were correlated. The analysis was adjusted for the number of ANC visits (offset option), which varied between women according to GA at inclusion and possible censored follow-up due to migration, consent withdrawal, or miscarriage. In addition, because the woman's susceptibility to malaria may differ depending on GA, with a higher capacity of the parasites to be selected by the placenta overtime [28] , the analysis was adjusted for GA. For that purpose, GA squared was used due to the quadratic relationship between GA and the risk of malaria. Gravidity was included into all final models because it is an important factor influencing malaria susceptibility during pregnancy [19] .
All variables with a P value below 0.2 in univariate analysis were included in the multivariate analysis. Then, the variables were eliminated step-by-step using the backward selection procedure. At this level, only variables for which the P value was less than 0.05 were kept. Stata version 13 for Windows (Stata Corp., College Station, TX) was used for all statistical analyses. 
RESULTS
As presented in the flowchart (Figure 1) , 1214 women of reproductive age were followed and 411 (33.8%) of them became pregnant. Twenty-four pregnant women were excluded, leaving 387 women for the present analysis. Of these 24 women, 9 had their first ANC visit after 15 wg, 10 withdrew their informed consent, and 5 had a miscarriage before the first ANC visit. Among the 387 women, 289 (74.7%) completed the first trimester follow-up, 61 (15.8%) had a miscarriage, 23 (5.9%) withdrew their informed consent, 13 (3.4%) migrated outside the study area, and 1 (0.2%) had an ectopic gestation before the end of the first trimester. Table 1 presents the general characteristics of the 387 pregnant women. The median duration of follow-up before conception was 3.9 months (interquartile range [IQR]: 1.77-7.49). The women's mean age was 26.8 years and 7.8% were primigravidae. The prevalence of microscopic malaria infection before pregnancy was 6.3% (10.0% vs 5.9% in primi-and multigravidae, respectively, P = .38). The pregnancy was confirmed at a mean of 6.7 wg. The mean number of visits during the first trimester, including both scheduled and unscheduled visits, was 2.3 (range 1-6). During pregnancy, more than 97% of women declared they had slept under an ITN the night before the visit.
The proportion of women with at least 1 microscopic malaria infection during the first trimester of pregnancy, including both scheduled and unscheduled visits, was 20.8% (26.7% vs 20.3% in primi-and multigravidae, respectively, P = .41); 7.3% of these infections were symptomatic. During unscheduled visits, malaria was detected in 21.6% of women; 12.2% of these infections were symptomatic. The overall incidence rate of new malaria infections was 19.7 infections per 100 person-months (95% CI, 15.8-24.5). Twelve women (3.1%) had 2 or more malaria infections. Among infected women, the mean geometric parasite density was 599 (95% CI, 416-863) parasites/µL. Women were more likely to be infected with malaria during the first trimester than before pregnancy (21% vs 6.3%; Figure 2 ). This difference was also observed when restricting the comparison to women at their first ANC visit (11.7% vs 6.3%).
Among the women who were screened for malaria during the first, second, and third month of pregnancy, the prevalence of malaria infection was 16.7%, 9.2%, and 11.2%, respectively (Table 2 ). Figure 3 presents the risk estimates (odds) of malaria infection throughout the first trimester of pregnancy after adjustment for gravidity. We observed that the risk of infection decreased at the end of the first month of pregnancy, then it remained constant until the end of the first trimester. While this trend was observed in multigravidae, the risk of malaria infection seemed to start decreasing only at the end of the first trimester in primigravidae (Figure 2) .
In univariate analysis, residence area, number of ANC visits, malaria before pregnancy, and GA were associated with malaria infection during the first trimester of pregnancy (Table 3) . We did not find any association between malaria and maternal age, socioeconomic status, season, and use of ITN at the time of malaria screening. In multivariate analysis, women infected with malaria before pregnancy remained significantly more likely to be infected with malaria during the first trimester (adjusted odds ratio [aOR]: 2.68; 95% CI, 1.24-5.78). In addition, the risk of malaria during the first trimester decreased significantly over time when GA was considered as a quadratic function. We did not evidence a statistical significant association between gravidity and the risk of malaria, although primigravidae seemed to be more likely to be infected than multigravidae (Figure 2 ). When stratifying the analysis on gravidity, we found that the risk of malaria infection decreased throughout the first trimester in multigravidae (aOR: 0.61; 95% CI, 0.38-0.96), but not in primigravidae (Supplementary Table S1 ). Finally, when restricting the analysis to women in their first ANC visit, early GA and malaria before conception remained significantly associated with malaria in the first trimester (data not shown).
DISCUSSION
Very little information on the burden of malaria in early pregnancy is currently available. We investigated malaria during the first trimester of pregnancy and its associated risk factors using a specifically designed study, in which women were recruited before conception. Prior studies of malaria in early pregnancy in sub-Saharan Africa countries have been limited by recruiting women late in the first trimester, which may have lead to misclassification errors (by categorizing some early infected women as noninfected) and underestimation of exposure [14] [15] [16] [17] [18] . We showed that malaria infection was highly prevalent in early pregnancy. Malaria before conception and early GA were the main related risk factors. We found that women during the first trimester of pregnancy were more infected with malaria than before conception. As data collection started before conception, each woman served as her own control, limiting the influence of confounding variables. This result was found regardless of gravidity. Malaria infection was highly incident during the first trimester (incidence rate of 19.7 infections per 100 person-months). This result is in accordance with previous publications [19, 29, 30] , which suggested that malaria occurring at the time of placentation (around 12 wg) may be responsible for up to 70% of the total exposure to placental infection [29] .
In our study, women infected with malaria before conception remained more likely to be infected with malaria during the first trimester of pregnancy. This association may partially be explained by the fact that these women had the same level of exposure to malaria during both periods. Another explanation may be that some of the infections detected in the first weeks of pregnancy were subpatent infections (ie, under level of detection of microscopy and RDT) present before conception. Because the proportion of microscopic infections was higher during pregnancy than before pregnancy, we assume that some of these prepregnancy infections were subpatent and that they became microscopic because of changes in women's physiology and immunity during early pregnancy [31, 32] , making women more susceptible to infectious diseases [33] . In order to confirm this hypothesis, parasites detected in women infected both before conception and during the first trimester of pregnancy have been collected and will be checked for genotype similarity.
Malaria infections were particularly prevalent during the first month of pregnancy and then decreased later in the first trimester (16.7%, 9.2%, and 11.2% at < 6 wg, 7-10 wg, and 11-14 wg, respectively). We believe this finding is not due to confounding for the following reasons. First, because a small proportion of women had symptomatic cases and infections were detected actively, it is unlikely that the very early infections (<6 wg) were overrepresented because they were symptomatic. Second, the lower prevalence of infections late in the first trimester (7-14 wg) may be related to the treatment of infections earlier in the first trimester, despite the short halflife of quinine used as malaria treatment in the first trimester [34] . However, when restricting the analysis to women at their first ANC visit, a similar decrease in malaria infection risk with GA was observed. Moreover, at this visit, no women reported to have been treated for malaria since the last preconceptional visit. Finally, the lower prevalence of infection in women with advanced GA (11-14 wg) compared to women with early GA (< 6 wg) at the first ANC visit was not related to a more recent treatment against malaria. Indeed, these women had a longer duration of follow-up before conception, and therefore a higher risk of new infection after initial treatment against malaria at enrolment. Of interest is the fact that the risk of malaria infection decreased throughout the first trimester in multigravidae. The susceptibility of women to malaria during pregnancy is related to the selection of specific parasites, which have the capacity to sequester within the placenta. With successive pregnancies, a pregnant woman develops increasing immunity to these parasites, allowing for a better control of infections [35] . VAR2CSA is the specific variant of P. falciparum proteins expressed on the surface of infected erythrocytes [36] that allows placenta sequestration. VAR2CSA-parasites have been detected as early as 7 wg [37] . In our study, multigravidae may have had the capacity to control infections due to VAR2CSA-parasites as early as 6 wg as compared to primigravidae, for whom malaria prevalence seemed to start decreasing only at the end of the first trimester. We also reported an important proportion of miscarriages (15.8%) in our study, which was higher than previously reported in African studies [38] . This may be related to our study design (preconceptional follow-up of women), which allowed us to identify very early miscarriages.
We did not evidence any seasonal effect on malaria risk. That might be explained by the specific environmental conditions in the study area. Indeed, most women (74.4%) lived in Sô-Ava district, which is a permanent natural lake providing ideal breeding conditions for mosquitoes throughout the year.
A major strength, and originality, of this study is that women were recruited before conception and then followed up from the very beginning of pregnancy. This allowed the detection of the earliest malaria infections, in particular those occurring before and during placental development, which usually stay undiagnosed. Moreover, GA could be estimated accurately using ultrasound before 15 wg, allowing for the precise determination of the timing of malaria infections during pregnancy. Nevertheless, this study has some limitations that should be considered. First, we did not specifically assess the woman's level of exposure to malaria, which highly influences the risk of infection. However, the analysis was adjusted for malaria infection before conception, a suitable proxy for the woman's level of exposure to malaria. In addition, the analysis included only 30 (7.8%) primigravidae, who are more likely to be infected with malaria during pregnancy. This low proportion was due to the fact that RECIPAL was implemented following a study on primigravidae conducted in the same area, making an important proportion of eligible primigravidae unavailable for our study [39] . Although this may not lead to a selection bias, findings based on analyses stratified on gravidity should be taken with caution.
There is growing evidence that malaria in the first trimester of pregnancy is deleterious for both the fetus and the mother [20] . Early malaria infections have been suggested to impair placentation [40, 41] , with possible chronic effects on fetal growth. Preventive strategies against malaria should clearly start from the first trimester of pregnancy. However, options are currently limited. As recommended later in pregnancy, prevention should rely on an integrated approach, combining safe drugs in the first trimester and antivectorial strategies (ITNs, potentially associated with indoor residual spraying). Artemisinin-based combination therapies have been shown to be safe during the first trimester of pregnancy [42] . Dihydroartemisinin-piperaquine is a well-tolerated, efficacious, and safe combination of drugs [42] [43] [44] , which may be a good option for early IPTp. However, the challenge remains to access women in the first trimester of pregnancy. Hence, preconceptional strategies against malaria in pregnancy may be of clear interest. A vaccine against VAR2CSA-parasites, which could elicit protective immunity prior to pregnancy to best protect women during early pregnancy, may be proposed as a complementary strategy to those b The number of antenatal care visits has been adjusted for the mutlivariate model using an "offset option. "
c Gravidity was included into the final model even if not significant in the univariate analysis.
already recommended during pregnancy. Such a vaccine is currently under evaluation [45] .
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